Is Ticagrelor in shortage in 2026? Get the latest update on Ticagrelor availability, pricing, and what you can do if your pharmacy is out of stock.
If you take Ticagrelor (brand name Brilinta) to protect your heart, you may have experienced difficulty filling your prescription at some point. Medication shortages and stock-outs have become a growing concern for patients across the country, and antiplatelet medications like Ticagrelor are no exception.
Here's what you need to know about Ticagrelor availability in 2026, why it may be hard to find at certain pharmacies, and what you can do about it.
As of early 2026, there is no official FDA-reported shortage of Ticagrelor. The FDA's Drug Shortage Database does not currently list Ticagrelor or Brilinta as being in shortage.
However, that doesn't mean every pharmacy has it on the shelf. Patients across the U.S. have reported localized stock-outs — situations where their specific pharmacy doesn't have Ticagrelor available, even though the drug is being manufactured and distributed nationally.
This is an important distinction: a national shortage means manufacturers can't make enough to meet demand. A localized stock-out means the drug exists in the supply chain but hasn't made it to your particular pharmacy.
Several factors contribute to difficulty finding Ticagrelor at your local pharmacy:
Generic Ticagrelor entered the U.S. market in 2023 after AstraZeneca's Brilinta patent expired. While this has been great for lowering costs, the transition period has created some supply chain friction. Multiple generic manufacturers are now competing for market share, and not all pharmacies stock every manufacturer's version.
Large chain pharmacies use automated inventory systems that order medications based on recent dispensing patterns. If a pharmacy hasn't filled many Ticagrelor prescriptions recently, their system may not keep it in stock. This is especially common at pharmacies in areas with fewer cardiology patients.
As generic Ticagrelor has become available, insurance companies have been updating their formularies. Some plans now prefer generic Ticagrelor over brand Brilinta, while others may have shifted patients to Clopidogrel as a lower-cost first-line option. These formulary shifts can affect which medications pharmacies choose to stock.
The cost picture has improved significantly thanks to generic competition:
The difference between full retail price and discount card price is enormous. If you're paying out of pocket, always use a discount card. See our full guide on how to save money on Ticagrelor for specific programs and tips.
Several developments have made it easier for patients to access Ticagrelor:
With several companies now producing generic Ticagrelor, the overall supply is more robust than it was during the brand-only era. If one manufacturer has a production issue, others can help fill the gap.
Mail-order and online pharmacies often have larger inventories and can ship medications directly to your door. If your local pharmacy is out of stock, a mail-order option through your insurance may be more reliable.
Medfinder allows you to check which pharmacies near you have Ticagrelor in stock in real time. This eliminates the frustrating process of calling pharmacy after pharmacy. Learn how to use it in our guide on how to check if a pharmacy has Ticagrelor in stock.
If your pharmacy just told you they're out of Ticagrelor, here's your action plan:
For more detailed strategies, see our post on how to find Ticagrelor in stock near you.
While Ticagrelor is not in a national shortage in 2026, individual pharmacies may still run out from time to time. The key is to be proactive: refill early, use tools like Medfinder to check stock, and have a backup plan with your doctor. Your heart health is too important to leave to chance.
For more about this medication, read what Ticagrelor is and how it's used or learn about Ticagrelor side effects.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.
%2C%20Color%3DOriginal.png)
